Research Article - (2012) Volume 3, Issue 7

Safety and Immunogenicity of Recombinant, Live Attenuated Tetravalent Dengue Vaccine (CYD- TDV) in Healthy Vietnamese Adults and Children

Ngoc Huu Tran1, Chan Quang Luong1, Thi Que Huong Vu1, Remi Forrat2, Jean Lang3, Quoc Dat Vu4, Alain Bouckenooghe4 and Tram Anh Wartel5*
1Ho Chi Minh City Pasteur Institute, Ho Chi Minh, Vietnam, E-mail: NgocHuuTran@gmail.com
2Sanofi Pasteur Clinical Department, Marcy L’Etoile, France, E-mail: NgocHuuTran@gmail.com
3Sanofi Pasteur R&D, Marcy L’Etoile, France, E-mail: NgocHuuTran@gmail.com
4Sanofi Pasteur Clinical R&D, Singapore, E-mail: NgocHuuTran@gmail.com
5Sanofi Pasteur Clinical R&D, Bangkok, Thailand, E-mail: NgocHuuTran@gmail.com
*Corresponding Author: